ADVANCED ENDOMETRIAL CARCINOMA

This is the first study in people to test a new oral medication called NKT3964. The main goals are to find a safe dose and see if the drug shows early signs of shrinking tumors in adults with advanced cancers that have spread and no longer respond to standard treatments. The stud…

This is an early-stage study to find safe doses of a new oral drug called IACS-6274. It will be tested alone and in combination with other cancer drugs in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check for side e…

This early-stage trial is testing the safety of combining a wearable device that uses electric fields to disrupt cancer cells with different drug combinations. It is for adults with advanced cancers in the abdomen or chest that have spread and who have run out of standard treatme…

This large, late-stage trial is comparing three different drug combinations for treating advanced or recurrent endometrial (uterine) cancer that has specific genetic features. It aims to see if adding a drug called bevacizumab to standard chemotherapy and immunotherapy helps pati…

This study is testing whether giving standard cancer treatments at home is as safe and effective as giving them in a clinic. It aims to see if receiving care at home reduces stress, improves quality of life, and is preferred by patients with advanced cancers. About 220 participan…

This early-stage study is testing the safety and best dose of a new two-drug combination for people with advanced solid tumors that have a specific marker called HER2. The treatment pairs an existing targeted cancer drug with a new pill that aims to block cancer cells' ability to…

This early-stage study is testing a new combination of two drugs, pelcitoclax and cobimetinib, for women with ovarian or endometrial cancer that has returned after prior treatment. The main goals are to find the safest and most effective dose and to check for side effects. Resear…